Joseph Knight, DPM
Foot & Ankle Surgery · Soldotna, AKNPI 1568923845
Payments from drug & device makers
What this record shows
Stryker accounts for 70.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $992 and has fallen 88.9% since, to $110 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in AK, where the typical reported total is $1,425.
Across 16 payments — averaging $84.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$953
- Restor3d, Inc.$176
- Paragon 28, Inc.$79
- Zimmer Biomet$65
- Kerecis Limited$32
- Smith+Nephew$25
- plus $15 from 1 others
What the payments were for
- Travel & lodging$56142%
- Food & beverage$78358%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 9 | $953 |
| Restor3d, Inc. | 1 | $176 |
| Paragon 28, Inc. | 1 | $79 |
| Zimmer Biomet | 2 | $65 |
| Kerecis Limited | 1 | $32 |
| Smith+Nephew | 1 | $25 |
| Acera Surgical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$671
How this compares
$1,345 in reported general payments places this provider in the 45th percentile of 21 foot & ankle surgery providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 24 | $703 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $227 |
| Cephalexin | 24 | $152 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $139 |
| Doxycycline Hyclate | 13 | $83 |
| Ondansetron Hcl | 15 | $47 |
| Meloxicam | 20 | $47 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Soldotna
- Ian BurtenshawSoldotna$5K
- Kristina LacySoldotna$32
- Regina FiaccoAnchorage$18K
- Sheryse MobleyAnchorage$15K
- Rabun FoxAnchorage$8K
- Eugene ChangAnchorage$7K
- Chloe MulliganAnchorage$4K
- Sean DunleavyAnchorage$4K
- Dustin HubbardFairbanks$4K
- Jennifer JansmaAnchorage$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.